Taichung, Taiwan

Kuo-Hsiung Lee




Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • Kaohsiung, TW (2010 - 2018)
  • Taichung, TW (2003 - 2020)

Company Filing History:


Years Active: 2003-2020

where 'Filed Patents' based on already Granted Patents

6 patents (USPTO):

Title: Kuo-Hsiung Lee: Innovator in Anticancer and Stroke Treatment

Introduction

Kuo-Hsiung Lee is a prominent inventor based in Taichung, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with anticancer properties and treatments for stroke. With a total of 6 patents to his name, Lee's work has the potential to impact the medical community significantly.

Latest Patents

One of his latest patents focuses on "Derivatives of curcuminoids and use thereof as an anticancer agent." This patent describes a series of novel bis(hydroxymethyl) alkanoate derivatives of curcuminoids that exhibit anticancer activity, specifically targeting breast cancer, colon cancer, and prostate cancer. Another notable patent is for a "Bicyclic compound and pharmaceutical composition thereof for treating stroke and use thereof." This disclosure relates to a bicyclic compound and its pharmaceutical composition, aimed at treating strokes effectively.

Career Highlights

Kuo-Hsiung Lee has worked with China Medical University, where he has likely collaborated with other researchers and contributed to various projects in the field of medicinal chemistry. His innovative approach to drug development has garnered attention in the scientific community.

Collaborations

Some of his notable coworkers include Sheng-Chu Kuo and Chang-Hai Tsai. Their collaborative efforts have likely enhanced the research and development of the compounds Lee has patented.

Conclusion

Kuo-Hsiung Lee's contributions to the fields of cancer treatment and stroke recovery through his innovative patents highlight his role as a significant inventor. His work continues to pave the way for advancements in pharmaceutical applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…